The largest database of trusted experimental protocols

C myc sirna

Manufactured by Santa Cruz Biotechnology

C-Myc siRNA is a small interfering RNA (siRNA) molecule designed to target and silence the expression of the c-Myc gene. The c-Myc gene is a well-known proto-oncogene that plays a critical role in cell proliferation, growth, and survival. C-Myc siRNA can be used as a research tool to investigate the functional role of c-Myc in various cellular processes and disease models.

Automatically generated - may contain errors

4 protocols using c myc sirna

1

Knockdown and Overexpression of c-Myc

Check if the same lab product or an alternative is used in the 5 most similar protocols
For gene knockdown experiments, c-Myc siRNA and non-targeting scrambled siRNA (NS) obtained from Santa Cruz Biotech were transfected into RPMI 8226 cells using PepMute™ siRNA transfection reagent (SignaGen Laboratories). For gene overexpression experiments, cells were transfected with pcDNA3.1-c-Myc, Flag-SUMO1 or HA-Ubiquitin plasmids (Addgene) using GenJet™ in vitro DNA transfection reagent (SignaGen Laboratories).
+ Open protocol
+ Expand
2

Modulating KRT13 and c-Myc in Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
For KRT13 overexpression, a cDNA containing the full-length open reading frame of human KRT13 (NM_153490) was subcloned into pLVX-AcGFP1-N1 (pLV) (Clontech, CA) by introducing EcoR I and BamH I sites. The construct of pLVX-AcGFP1-N1-KRT13 (pLV-KRT13) was confirmed by DNA sequencing. The plasmid DNA was transfected to the 293 T cells to produce lentiviral particles, following the manufacturer’s instructions (System Biosciences, Mountain View, CA). MCF7 cells were transduced with the lentivirus and selected with puromycin (2 µg/ml for 2 weeks). For shRNA-mediated knockdown, non-targeting control or KRT13 shRNA lentiviral particles (Santa Cruz Biotechnology, Dallas, Texas) were used to infect the HCC1954 cells. The plasmid pcDNA3-c-Myc (Addgene, Cambridge, MA) was used to generate c-Myc-overexpressing cells. To silence c-Myc, cells were transfected with c-Myc siRNA (Santa Cruz Biotechnology) using Lipofectamine 2000 transfection reagent (Invitrogen, Carlsbad, CA).
+ Open protocol
+ Expand
3

siRNA Knockdown of PDGFR, JAG2, and c-MYC

Check if the same lab product or an alternative is used in the 5 most similar protocols
PDGFRα siRNA duplex (5′-GGAGGAUG AUGAUUCUGCCAUUAUA-3′ ), PDGFRβ siRNA duplex (5′-UCACGGAAAUAACUGAGAUCACCAU-3′ ), and control (mock) siRNA duplex (5′-ACAUCACGUACGCG GAAUACUUCGA-3′) were obtained from Invitrogen. JAG2 siRNA, a pool of 4 siRNA duplexes (5′-GCAAGGAAGCUGUGUGUAA-3′, 5′-GCGUGUGC CUUAAGGAGUA-3′, 5′-GAACGGCGCUCGCUGC UAU-3′, 5′-GGUCGUACUUGCACUCACA-3′ ) were purchased from Dharmacon. c-MYC siRNA is a pool of 3 different siRNA duplexes (5′-CCCAAGGUAGUUAUCCUUAtt-3′, 5′-GGAAACGAC GAGAACAGUUtt-3′, and 5′-CCUGAGCAAUCA CCUAUGAtt-3′ ) were purchased from Santa Cruz. Transfection of siRNA was performed using Lipofectamine™ (Invitrogen) according to the company's instructions.
+ Open protocol
+ Expand
4

siRNA Knockdown and Resveratrol Treatment Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
RNA interference was carried out by transfecting cells with c-Myc siRNA (Santa Cruz Biotechnology, sc-29226), SIRT1 siRNA (Santa Cruz Biotechnology, sc-40986), or control scrambled siRNA (Santa Cruz Biotechnology, sc-37007) using Lipofectamine 2000 for 12 h in Opti-MEM according to the manufacturer’s instructions. After transfection, cells were transferred to full-growth medium for another 12-h incubation prior to analysis for further studies. HUVECs were treated with HG (33 mM) for 72 h with or without 10 μM RES.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!